Company Directory > Pharma > Springer Nature
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Springer Nature and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

Springer Nature

London, United Kingdom / Berlin, Germany
VISIT WEBSITE
Springer Nature is a leading global research, educational, and professional publisher. Formed in 2015 through the merger of Nature Publishing Group, Macmillan Education, and Springer Science+Business Media, the company provides access to a vast portfolio of journals, books, and databases, including the flagship journal Nature. The company operates across three main segments: Research, Education, and Health. It serves millions of researchers, educators, and health professionals worldwide, maintaining a strong focus on open access and the dissemination of scientific discovery.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:-
Industry:Publishing
Sub-Industry:Academic and Scientific Publishing
SIZE & FINANCIALS
Employees:10000+
Revenue:$2B+
Founded:2015
Ownership:public
Status:operating
FUNDING
Investors:Holtzbrinck Publishing Group, BC Partners
STOCK
Exchange:Frankfurt Stock Exchange
Ticker:SPG
0
CORPORATE STRUCTURE
Subsidiaries:Nature Portfolio, Springer, Palgrave Macmillan, Macmillan Education
Key Partnerships:Various academic institutions and research societies worldwide for journal publishing.
COMPETITION
Position:Leader
Competitors:Elsevier, Wiley, Taylor & Francis, Science (AAAS)
LEADERSHIP
Key Executives:
Frank Vrancken Peeters - CEO
LINKS
Website:nature.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Springer Nature. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.